N@N

GPRO, CCI, LEG, THOR, AKAM, KNSY, Expected to Trade Lower After Bearish Insider Trading

^{Published on 2011-09-06 09:31:04 - WOPRAI}
 

September 6, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. GEN-PROBE INC. (NASDAQ:GPRO), CROWN CASTLE INTL CORP (NYSE:CCI), LEGGETT & PLATT, INCORPORATED (NYSE:LEG), THORATEC CORPORATION (NASDAQ:THOR), AKAMAI TECHNOLOGIES, INC. (NASDAQ:AKAM), KENSEY NASH CORPORATION (NASDAQ:KNSY) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

     Symbol     Company Name                        Insider Name                        Role        Shares         Insider Score     Avg 6 Month Return     # of Dec. 
     GPRO       GEN-PROBE INC.                      Dewalt, Diana R                     O           3,000          85                -14.1%                 6         
     CCI        CROWN CASTLE INTL CORP              Martin, James Landis                D           42,178         78                -8.8%                  5         
     LEG        LEGGETT & PLATT, INCORPORATED       Hauser, Paul R                      O           72,068         75                -7.0%                  8         
     THOR       THORATEC CORPORATION                Cole, James Daniel                  D           3,000          98                -19.3%                 14        
     AKAM       AKAMAI TECHNOLOGIES, INC.           Sherman, J Donald                   CFO         5,000          88                -41.3%                 5         
     KNSY       KENSEY NASH CORPORATION             Maupay, Walter R Jr                 D           4,000          95                -13.6%                 13        

GEN-PROBE INC. (NASDAQ:GPRO) - Gen-Probe Incorporated engages in the development, manufacture, and marketing of nucleic acid tests used primarily to diagnose human diseases and screen donated human blood in North America and internationally. The company markets a portfolio of products to detect infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, and other infections. Its primarily product line includes APTIMA Combo 2 assay, APTIMA CT, APTIMA GC assays, and PACE family of assays to detect chlamydia and gonorrhea; APTIMA Trichomonas ASRs to detect trichomonas; APTIMA HPV assay to detect 14 sub-types of high-risk HPV associated with cervical cancer; and AccuProbe Group B Streptococcus (GBS) assay to detect GBS from culture. The companys product line also include APTIMA HIV-1 assay to detect RNA from HIV-1, the virus that causes AIDS; APTIMA HCV assay to detect RNA from the hepatitis C virus; and ASRs for quantitative HCV testing to quantify HCV viral load. It also offers Pro-Flu+, Pro-Flu ST, ProGastro Cd, AMPLIFIED MTD, and GAS Direct for various respiratory infectious diseases; LIFECODES HLA DNA typing kits and LIFECODES LifeScreen antibody screening kits in the transplant diagnostics field; Procleix HIV-1/HCV assay, Procleix Ultrio assay, Procleix Ultrio Plus assay, and Procleix WNV assay for the blood donor screening market; and TIGRIS and Direct Tube Sampling instrument systems to develop instrumentation. In addition, the companys developing products include PANTHER, an automated testing instrument. Further, the company offers PROGENSA PCA3 and PCA3 ASRs to detect the PCA3 gene. The companys customers include reference laboratories, public health institutions, and hospitals. It has a collaboration agreement with Novartis Vaccines and Diagnostics, Inc. for the research, development, and manufacturing of its blood screening products. The company was founded in 1983 and is headquartered in San Diego, California.

CROWN CASTLE INTL CORP (NYSE:CCI) - Crown Castle International Corp., through its subsidiaries, owns, operates, and leases towers and other wireless infrastructure primarily in the United States and Australia. Its infrastructure includes distributed antenna system (DAS) networks, as well as rooftop installations. The company involves in the rental of antenna space of its towers to wireless communications companies. It also provides network services relating to its towers, which primarily include antenna installations and subsequent augmentations, as well as additional services, such as site acquisition, architectural and engineering, zoning and permitting, other construction, and other services related network development. As of December 31, 2010, it owned, leased, or managed approximately 23,900 towers, including 43 completed DAS networks. The company was founded in 1994 and is headquartered in Houston, Texas.

LEGGETT & PLATT, INCORPORATED (NYSE:LEG) - Leggett & Platt, Incorporated designs and produces a range of engineered components and products worldwide. It operates in four segments: Residential Furnishings, Commercial Fixturing & Components, Industrial Materials, and Specialized Products. The Residential Furnishings segment manufactures or distributes bedding, furniture, consumer, fabric, and carpet underlay products to manufacturers of finished bedding products or upholstered furniture for residential use. The Commercial Fixturing & Components segment offers fixture and display, and office furniture components to retail chains and specialty shops; brand name marketers and distributors of consumer products; and office, institutional, and commercial furniture manufacturers. The Industrial Materials segment provides steel rods; drawn wire; steel billets; fabricated wire products, such as shaped wire for automotive and medical supply applications; tying heads, boxed wire, and parts for automatic baling equipment; coated wire products, including dishwasher racks; and wire retail fixtures and point-of-purchase displays. This segment also offers welded steel tubing and fabricated tube components. The Specialized Products segment provides manual and power lumbar support and massage systems for automotive seating; seat suspension systems; automotive control cables, such as shift cables, cruise-control cables, seat belt cables, accelerator cables, seat control cables, and latch release cables; low voltage motors and actuation assemblies; and formed metal and wire components for seat frames, as well as quilting machines for mattress covers, machines used to shape wire into springs, and industrial sewing/finishing machines. It also offers commercial vehicle products, such as van interiors; docking stations that mount computers and other electronic equipment inside vehicles; and specialty trailers used by telephone, cable, and utility companies. The company was founded in 1883 and is headquartered in Carthage, Missouri.

THORATEC CORPORATION (NASDAQ:THOR) - Thoratec Corporation develops, manufactures, and markets proprietary medical devices used for circulatory support. It operates in two divisions, Cardiovascular and International Technidyne Corporation (ITC). Cardiovascular division offers medical devices used for mechanical circulatory support (MCS). Its products include HeartMate II, an implantable left ventricular assist device consisting of a miniature rotary blood pump to provide intermediate and long-term MCS; HeartMate XVE, an implantable device for intermediate and long-term MCS; and Paracorporeal Ventricular Assist Device, an external device approved for bridge-to-transplantation and post-cardiotomy myocardial recovery to provide left, right, and biventricular MCS. This division also offers Implantable Ventricular Assist Device, an implantable device, which provides left, right, and biventricular MCS; CentriMag that provides 6 hours support for patients requiring short-term extracorporeal circulatory support during cardiac surgery, as well as used as a right ventricular assist device for 30 days for patients in cardiogenic shock due to acute right ventricular failure; and Vectra Vascular Access Graft, which is used as a shunt between an artery and a vein. ITC division offers point-of-care diagnostic test systems that monitor blood coagulation, as well as monitor blood gas/electrolytes, oxygenation, and chemistry status. This segment also provides incision products to obtain a patients blood sample for diagnostic testing and screening for platelet function. It offers its products to hospital point-of-care market; and the alternate site point-of-care market comprising physicians offices, long-term care facilities, clinics, visiting nurse associations, and home healthcare companies. Thoratec Corporation markets its products through direct sales force and distributors in the United States and internationally. The company was founded in 1976 and is headquartered in Pleasanton, California.

AKAMAI TECHNOLOGIES, INC. (NASDAQ:AKAM) - Akamai Technologies, Inc. provides services for accelerating and improving the delivery of content and applications over the Internet in the United States and internationally. The company offers Application Performance solutions that improve the performance of dynamic applications used by enterprises to connect with their employees, suppliers, and customers. Its Application Performance solutions include Web Application Accelerator, which enables enterprises to run various applications; and IP Application Accelerator that is designed to address core Internet weaknesses to optimize the performance and real-time sensitivity associated with IP-enabled applications delivered over Internet-related protocols. It also provides Digital Asset solutions that enable enterprises to execute their large file management and distribution strategies. The companys Digital Asset solutions include Akamai Media Delivery solution that delivers media content on behalf of its customers; and Electronic Software Delivery solution, which handles the distribution of software for its customers. In addition, it offers Dynamic Site solutions, which accelerate business-to-consumer Websites that integrate collaborative content and applications into their online architecture; Advertising Decision solutions that enable advertisers, agencies, publishers, and networks to buy and sell advertising; and custom solutions to commercial and government customers. Additionally, the company offers other solutions, such as EdgeControl tools that provide reporting and management capabilities; network data feeds and Website analytics, which provide customers with real time data about the performance of their content and applications over the Internet; and performance management services that help customers better understand their Web operations with tools that measure various aspects of an applications performance. Akamai Technologies, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts.

KENSEY NASH CORPORATION (NASDAQ:KNSY) - Kensey Nash Corporation operates as a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The company specializes in the product development and for applying unique technology in the field of resorbable biomaterials. It offers a range of products, which are sold through strategic partners in multiple medical markets, including, the cardiology, orthopaedic, sports medicine, spine, endovascular, and general surgery markets. Kensey Nash Corporation was incorporated in 1984 and is headquartered in Exton, Pennsylvania.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net